the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Thales faces Anglo-French investigation over suspected bribery

LONDON: Britain’s Serious Fraud Office (SFO) said on Thursday it was investigating suspected bribery and corruption at Thales, Europe’s largest defence technology company.

Investigators from the SFO and France’s Parquet National Financier (PNF) have informed Paris-headquartered Thales of the probe, the SFO added in a statement.

A Thales spokesperson confirmed that the company was cooperating with the two authorities in an investigation related to four of its entities in France and Britain.

“The group complies with all national and international regulations. As the investigation is on-going, Thales will not comment further,“ the spokesperson said.

A French judicial source told Reuters that the investigation related to an arms contract in Asia.

The probe centres on possible charges of bribery of a foreign public official, influence trafficking, the handling of stolen goods and money laundering, the French source added.

Thales employs more than 7,000 staff in Britain across 16 sites. Its military and civil products range from sub-hunting sonars to biometric identity systems for banks, and from satellites to seat-back entertainment systems for airlines.

“Working collaboratively with our international partners is a crucial factor in the fight against international corruption and with this case I hope to reinforce the SFO and PNF’s long-standing relationship,“ said SFO Director Nick Ephgrave.

“We will together rigorously pursue every avenue in our investigation into these serious allegations,“ he added.

In June, police in France, Spain and the Netherlands had searched the offices of Thales as part of a corruption probe.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings